| Dr Jambur Eriah Chandrashekar, MD | |
|
81719 Dr. Carreon Blvd, Ste A, Indio, CA 92201 | |
| (760) 347-0707 | |
| (760) 347-3378 |
| Full Name | Dr Jambur Eriah Chandrashekar |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 50 Years |
| Location | 81719 Dr. Carreon Blvd, Indio, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013098557 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | A33785 (California) | Secondary |
| 207R00000X | Internal Medicine | A33785 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kidney Institute Of The Desert | Indio, CA | Dialysis facility |
| Coachella Kidney Institute, Llc | Coachella, CA | Dialysis facility |
| La Quinta Kidney Center, Llc | La quinta, CA | Dialysis facility |
| John F Kennedy Memorial Hospital | Indio, CA | Hospital |
| Eisenhower Medical Center | Rancho mirage, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coachella Valley Nephrology Inc | 9537303714 | 3 |
| Valley Comprehensive Medical Group Inc | 4587601786 | 3 |
News Archive
Communication with COVID-19 vaccine trial participants and their communities, pre, during and post-trial is key to finding and delivering a successful vaccine, say social scientists from the Social Science in Humanitarian Action Platform, in a new brief published today.
VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.
Varian Medical Systems, Inc. today announced that CURE Foundation has placed an order for five Varian TrueBeam™ systems for stereotactic radiosurgery and radiation therapy.
The United States may be losing ground as the leader in biomedical research and within the next five years will be second to China in the funds it spends for R&D, according to Francis Collins, M.D., Ph.D, director of the National Institutes of Health.
Physicians use different definitions of "reasonable medical certainty" when testifying as expert witnesses in child abuse cases. The variability is troubling because it could result in flawed rulings, according to researchers at Penn State College of Medicine.
› Verified 8 days ago
| Entity Name | Valley Comprehensive Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164506358 PECOS PAC ID: 4587601786 Enrollment ID: O20050408001131 |
News Archive
Communication with COVID-19 vaccine trial participants and their communities, pre, during and post-trial is key to finding and delivering a successful vaccine, say social scientists from the Social Science in Humanitarian Action Platform, in a new brief published today.
VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.
Varian Medical Systems, Inc. today announced that CURE Foundation has placed an order for five Varian TrueBeam™ systems for stereotactic radiosurgery and radiation therapy.
The United States may be losing ground as the leader in biomedical research and within the next five years will be second to China in the funds it spends for R&D, according to Francis Collins, M.D., Ph.D, director of the National Institutes of Health.
Physicians use different definitions of "reasonable medical certainty" when testifying as expert witnesses in child abuse cases. The variability is troubling because it could result in flawed rulings, according to researchers at Penn State College of Medicine.
› Verified 8 days ago
| Entity Name | Coachella Valley Nephrology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871832543 PECOS PAC ID: 9537303714 Enrollment ID: O20130910000946 |
News Archive
Communication with COVID-19 vaccine trial participants and their communities, pre, during and post-trial is key to finding and delivering a successful vaccine, say social scientists from the Social Science in Humanitarian Action Platform, in a new brief published today.
VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.
Varian Medical Systems, Inc. today announced that CURE Foundation has placed an order for five Varian TrueBeam™ systems for stereotactic radiosurgery and radiation therapy.
The United States may be losing ground as the leader in biomedical research and within the next five years will be second to China in the funds it spends for R&D, according to Francis Collins, M.D., Ph.D, director of the National Institutes of Health.
Physicians use different definitions of "reasonable medical certainty" when testifying as expert witnesses in child abuse cases. The variability is troubling because it could result in flawed rulings, according to researchers at Penn State College of Medicine.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jambur Eriah Chandrashekar, MD 81719 Dr. Carreon Blvd, Ste 2a, Indio, CA 92201-5518 Ph: (760) 342-8898 | Dr Jambur Eriah Chandrashekar, MD 81719 Dr. Carreon Blvd, Ste A, Indio, CA 92201 Ph: (760) 347-0707 |
News Archive
Communication with COVID-19 vaccine trial participants and their communities, pre, during and post-trial is key to finding and delivering a successful vaccine, say social scientists from the Social Science in Humanitarian Action Platform, in a new brief published today.
VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.
Varian Medical Systems, Inc. today announced that CURE Foundation has placed an order for five Varian TrueBeam™ systems for stereotactic radiosurgery and radiation therapy.
The United States may be losing ground as the leader in biomedical research and within the next five years will be second to China in the funds it spends for R&D, according to Francis Collins, M.D., Ph.D, director of the National Institutes of Health.
Physicians use different definitions of "reasonable medical certainty" when testifying as expert witnesses in child abuse cases. The variability is troubling because it could result in flawed rulings, according to researchers at Penn State College of Medicine.
› Verified 8 days ago
Dr. Sharon Reuben, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 46883 Monroe St Ste 200, Indio, CA 92201 Phone: 760-254-8960 Fax: 760-208-1802 | |
Mr. Mustaqeem Ahmed Qazi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 82013 Dr Carreon Blvd, C, Indio, CA 92201 Phone: 760-863-0138 Fax: 760-863-0471 | |
Dr. Ian David Kaiser, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 46883 Monroe St Ste 200, Indio, CA 92201 Phone: 760-254-8960 Fax: 760-208-1802 | |
Dr. Javed Ahmad, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 81833 Doctor Carreon Blvd Ste 2, Indio, CA 92201 Phone: 760-863-0155 Fax: 760-863-0199 | |
Dr. Tahir Majid I, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 81709 Doctor Carreon Blvd, C-4, Indio, CA 92201 Phone: 760-342-8181 Fax: 760-342-0946 | |
Dr. Gregory Kuldanek, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 82915 Avenue 48, Indio, CA 92201 Phone: 760-352-4414 Fax: 616-957-7913 |